689 related articles for article (PubMed ID: 29137967)
1. Procedural and thirty-day outcomes following transfemoral implantation of the fully repositionable and retrievable Lotus valve without routine pre-dilatation in a consecutive patient cohort: a single-center experience.
Ruparelia N; Thomas K; Newton JD; Grebenik K; Keiralla A; Krasopoulos G; Sayeed R; Banning AP; Kharbanda RK
Cardiovasc Revasc Med; 2018; 19(1 Pt B):78-82. PubMed ID: 29137967
[TBL] [Abstract][Full Text] [Related]
2. Outcome With the Repositionable and Retrievable Boston Scientific Lotus Valve Compared With the Balloon-Expandable Edwards Sapien 3 Valve in Patients Undergoing Transfemoral Aortic Valve Replacement.
Seeger J; Gonska B; Rottbauer W; Wöhrle J
Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28566290
[TBL] [Abstract][Full Text] [Related]
3. Transfemoral aortic valve implantation with new-generation devices: the repositionable Lotus vs. the balloon-expandable Edwards Sapien 3 valve.
Nai Fovino L; Badawy MRA; Fraccaro C; D'Onofrio A; Purita PAM; Frigo AC; Tellaroli P; Mauro A; Tusa M; Napodano M; Gerosa G; Iliceto S; Bedogni F; AbdelRheim AER; Tarantini G
J Cardiovasc Med (Hagerstown); 2018 Nov; 19(11):655-663. PubMed ID: 30299408
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience.
Giannini F; Latib A; Montorfano M; Ruparelia N; Romano V; Longoni M; Ferri L; Jabbour R; Mangieri A; Regazzoli D; Ancona M; Buzzatti N; Azzalini L; Tanaka A; Agricola E; Chieffo A; Alfieri O; Colombo A
Catheter Cardiovasc Interv; 2018 Apr; 91(5):966-974. PubMed ID: 28941127
[TBL] [Abstract][Full Text] [Related]
5. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
[TBL] [Abstract][Full Text] [Related]
6. A feasibility study of transaxillary TAVI with the lotus valve.
Doshi SN; George S; Kwok CS; Mechery A; Mamas M; Ludman PF; Townend JN; Bhabra M
Catheter Cardiovasc Interv; 2018 Sep; 92(3):542-549. PubMed ID: 29130619
[TBL] [Abstract][Full Text] [Related]
7. Use of a Repositionable and Fully Retrievable Aortic Valve in Routine Clinical Practice: The RESPOND Study and RESPOND Extension Cohort.
Van Mieghem NM; Wöhrle J; Hildick-Smith D; Bleiziffer S; Blackman DJ; Abdel-Wahab M; Gerckens U; Linke A; Ince H; Wenaweser P; Allocco DJ; Meredith IT; Falk V
JACC Cardiovasc Interv; 2019 Jan; 12(1):38-49. PubMed ID: 30621976
[TBL] [Abstract][Full Text] [Related]
8. Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.
Montone RA; Testa L; Fraccaro C; Montorfano M; Castriota F; Nerla R; Angelillis M; Tusa M; Giannini F; Garatti A; Tarantini G; Petronio AS; Brambilla N; Bedogni F
Catheter Cardiovasc Interv; 2017 Dec; 90(7):1206-1211. PubMed ID: 28145039
[TBL] [Abstract][Full Text] [Related]
9. Incidence and predictors of permanent pacemaker implantation following treatment with the repositionable Lotus™ transcatheter aortic valve.
Zaman S; McCormick L; Gooley R; Rashid H; Ramkumar S; Jackson D; Hui S; Meredith IT
Catheter Cardiovasc Interv; 2017 Jul; 90(1):147-154. PubMed ID: 27862860
[TBL] [Abstract][Full Text] [Related]
10. Transfemoral Transcatheter Aortic Valve-in-Valve Implantation for Aortic Valve Bioprosthesis Failure With the Fully Repositionable and Retrievable Lotus Valve: A Single-Center Experience.
Ruparelia N; Thomas K; Newton JD; Grebenik K; Keiralla A; Krasopoulos G; Sayeed R; Banning AP; Kharbanda RK
J Invasive Cardiol; 2017 Sep; 29(9):315-319. PubMed ID: 28706126
[TBL] [Abstract][Full Text] [Related]
11. Single-center evaluation of a next generation fully repositionable and retrievable transcatheter aortic valve replacement.
Berntorp K; Koul S; Nozohoor S; Harnek J; Bjursten H; Götberg M
BMC Cardiovasc Disord; 2019 Feb; 19(1):44. PubMed ID: 30808296
[TBL] [Abstract][Full Text] [Related]
12. 1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II Study.
Meredith IT; Walters DL; Dumonteil N; Worthley SG; Tchétché D; Manoharan G; Blackman DJ; Rioufol G; Hildick-Smith D; Whitbourn RJ; Lefèvre T; Lange R; Müller R; Redwood S; Feldman TE; Allocco DJ; Dawkins KD
JACC Cardiovasc Interv; 2016 Feb; 9(4):376-384. PubMed ID: 26892084
[TBL] [Abstract][Full Text] [Related]
13. Transcatheter Aortic Valve Replacement Using the Repositionable LOTUS Valve: United Kingdom Experience.
Rampat R; Khawaja MZ; Byrne J; MacCarthy P; Blackman DJ; Krishnamurthy A; Gunarathne A; Kovac J; Banning A; Kharbanda R; Firoozi S; Brecker S; Redwood S; Bapat V; Mullen M; Aggarwal S; Manoharan G; Spence MS; Khogali S; Dooley M; Cockburn J; de Belder A; Trivedi U; Hildick-Smith D
JACC Cardiovasc Interv; 2016 Feb; 9(4):367-372. PubMed ID: 26892082
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinical outcome of persistent left bundle branch block after transfemoral aortic valve implantation.
Keßler M; Gonska B; Seeger J; Rottbauer W; Wöhrle J
Catheter Cardiovasc Interv; 2019 Feb; 93(3):538-544. PubMed ID: 30298700
[TBL] [Abstract][Full Text] [Related]
15. Effect of aorto-ventricular angulation on procedural success in transcatheter aortic valve replacements with the Lotus Valve system.
Rashid HN; McCormick LM; Talman AH; Ihdayhid AR; Nerlekar N; Amiruddin AS; Cameron J; Nasis A; Meredith IT; Gooley RP
Catheter Cardiovasc Interv; 2018 Jun; 91(7):1365-1370. PubMed ID: 29210168
[TBL] [Abstract][Full Text] [Related]
16. Conduction Abnormalities and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement Using the Repositionable LOTUS Device: The United Kingdom Experience.
Rampat R; Khawaja MZ; Hilling-Smith R; Byrne J; MacCarthy P; Blackman DJ; Krishnamurthy A; Gunarathne A; Kovac J; Banning A; Kharbanda R; Firoozi S; Brecker S; Redwood S; Bapat V; Mullen M; Aggarwal S; Manoharan G; Spence MS; Khogali S; Dooley M; Cockburn J; de Belder A; Trivedi U; Hildick-Smith D
JACC Cardiovasc Interv; 2017 Jun; 10(12):1247-1253. PubMed ID: 28641846
[TBL] [Abstract][Full Text] [Related]
17. Initial Experience of a Second-Generation Self-Expanding Transcatheter Aortic Valve: The UK & Ireland Evolut R Implanters' Registry.
Kalra SS; Firoozi S; Yeh J; Blackman DJ; Rashid S; Davies S; Moat N; Dalby M; Kabir T; Khogali SS; Anderson RA; Groves PH; Mylotte D; Hildick-Smith D; Rampat R; Kovac J; Gunarathne A; Laborde JC; Brecker SJ
JACC Cardiovasc Interv; 2017 Feb; 10(3):276-282. PubMed ID: 28183467
[TBL] [Abstract][Full Text] [Related]
18. Transcatheter aortic valve implantation in severe calcified annulus using the Lotus valve system: Increased incidence of fatal major vascular complications.
Conzelmann LO; Würth A; Balthasar V; Neuber C; Tzamalis P; Gonska BD; Schmitt C; Mehlhorn U; Schymik G
Catheter Cardiovasc Interv; 2020 Jan; 95(1):E21-E29. PubMed ID: 31115146
[TBL] [Abstract][Full Text] [Related]
19. Implantation and 30-Day Follow-Up on All 4 Valve Sizes Within the Portico Transcatheter Aortic Bioprosthetic Family.
Möllmann H; Linke A; Holzhey DM; Walther T; Manoharan G; Schäfer U; Heinz-Kuck K; Van Boven AJ; Redwood SR; Kovac J; Butter C; Søndergaard L; Lauten A; Schymik G; Worthley SG
JACC Cardiovasc Interv; 2017 Aug; 10(15):1538-1547. PubMed ID: 28797431
[TBL] [Abstract][Full Text] [Related]
20. Minimally invasive versus transapical versus transfemoral aortic valve implantation: A one-to-one-to-one propensity score-matched analysis.
Furukawa N; Kuss O; Emmel E; Scholtz S; Scholtz W; Fujita B; Ensminger S; Gummert JF; Börgermann J
J Thorac Cardiovasc Surg; 2018 Nov; 156(5):1825-1834. PubMed ID: 29861110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
